Detalhe da pesquisa
1.
The effect of maternal poliovirus antibodies on the immune responses of infants to poliovirus vaccines.
BMC Infect Dis
; 20(1): 641, 2020 Aug 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-32867698
2.
Immunogenicity and Safety of a Sabin Strain-Based Inactivated Polio Vaccine: A Phase 3 Clinical Trial.
J Infect Dis
; 220(10): 1551-1557, 2019 10 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-30958543
3.
Safety and immunogenicity of a recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in Sierra Leone: a single-centre, randomised, double-blind, placebo-controlled, phase 2 trial.
Lancet
; 389(10069): 621-628, 2017 02 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-28017399
4.
Long-term efficacy of a hepatitis E vaccine.
N Engl J Med
; 372(10): 914-22, 2015 Mar 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-25738667
5.
Clinical significance of peripheral circulating tumor cell counts in colorectal polyps and non-metastatic colorectal cancer.
World J Surg Oncol
; 16(1): 13, 2018 Jan 22.
Artigo
em Inglês
| MEDLINE | ID: mdl-29357895
6.
2-Year Efficacy, Immunogenicity, and Safety of Vigoo Enterovirus 71 Vaccine in Healthy Chinese Children: A Randomized Open-Label Study.
J Infect Dis
; 215(1): 56-63, 2017 Jan 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-28077584
7.
Efficacy, safety, and immunogenicity of an enterovirus 71 vaccine in China.
N Engl J Med
; 370(9): 818-28, 2014 Feb 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-24571754
8.
Safety and immunogenicity of a novel recombinant adenovirus type-5 vector-based Ebola vaccine in healthy adults in China: preliminary report of a randomised, double-blind, placebo-controlled, phase 1 trial.
Lancet
; 385(9984): 2272-9, 2015 Jun 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25817373
9.
[Analysis of seroepidemiology of enterovirus 71 diseases in children in Jiangsu province].
Zhonghua Yu Fang Yi Xue Za Zhi
; 49(12): 1047-51, 2015 Dec.
Artigo
em Zh
| MEDLINE | ID: mdl-26887297
10.
Baseline prevalence and type distribution of human papillomavirus in healthy Chinese women aged 18-25 years enrolled in a clinical trial.
Int J Cancer
; 135(11): 2604-11, 2014 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24740547
11.
Efficacy, immunogenicity and safety of the HPV-16/18 AS04-adjuvanted vaccine in healthy Chinese women aged 18-25 years: results from a randomized controlled trial.
Int J Cancer
; 135(11): 2612-22, 2014 Dec 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-24740596
12.
Immunogenicity and safety of an enterovirus 71 vaccine in healthy Chinese children and infants: a randomised, double-blind, placebo-controlled phase 2 clinical trial.
Lancet
; 381(9871): 1037-45, 2013 Mar 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-23352749
13.
Efficacy, safety, and immunology of an inactivated alum-adjuvant enterovirus 71 vaccine in children in China: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Lancet
; 381(9882): 2024-32, 2013 Jun 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-23726161
14.
[Value of computer-assisted slide-screening system in ThinPrep cervical cytology].
Zhonghua Bing Li Xue Za Zhi
; 42(9): 609-12, 2013 Sep.
Artigo
em Zh
| MEDLINE | ID: mdl-24314247
15.
The lncRNA FENDRR inhibits colorectal cancer progression via interacting with and triggering GSTP1 ubiquitination by FBX8.
Heliyon
; 9(12): e23161, 2023 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-38144314
16.
A randomized, open-label, phase 3 study evaluating safety and immunogenicity of 13-valent pneumococcal conjugate vaccine in Chinese infants and children under 6 years of age.
Hum Vaccin Immunother
; 19(2): 2235926, 2023 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-37549923
17.
Safety of AS04-HPV-16/18 vaccine in Chinese women aged 26 years and older and long-term protective effect in women vaccinated at age 18-25 years: A 10-year follow-up study.
Asia Pac J Clin Oncol
; 19(4): 458-467, 2023 Aug.
Artigo
em Inglês
| MEDLINE | ID: mdl-36101936
18.
Safety and immunogenicity of an Escherichia coli-produced 9-valent human papillomavirus L1 virus-like particle vaccine (types 6/11/16/18/31/33/45/52/58) in healthy adults: an open-label, dose-escalation phase 1 clinical trial.
Lancet Reg Health West Pac
; 34: 100731, 2023 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-37283969
19.
Immunogenicity and safety of an Escherichia coli-produced human papillomavirus (types 6/11/16/18/31/33/45/52/58) L1 virus-like-particle vaccine: a phase 2 double-blind, randomized, controlled trial.
Sci Bull (Beijing)
; 68(20): 2448-2455, 2023 10 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37743201
20.
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine administered in a prime-boost regimen among Chinese infants: a randomized, double blind phase III clinical trial.
Hum Vaccin Immunother
; 18(1): 2019498, 2022 12 31.
Artigo
em Inglês
| MEDLINE | ID: mdl-35192784